Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  VYNE Therapeutics Inc.    VYNE

VYNE THERAPEUTICS INC.

(VYNE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

VYNE THERAPEUTICS INC. : Results of Operations and Financial Condition (form 8-K)

11/05/2020 | 07:15am EST
Item 2.02 Results of Operations and Financial Condition.
On November 5, 2020, VYNE Therapeutics Inc. issued a press release announcing
its financial results for the quarter ended September 30, 2020. The press
release is being furnished as Exhibit 99.1.
The information in this Item 2.02 of this Form 8-K and the Exhibit 99.1 attached
hereto shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to
the liabilities of that Section, or incorporated by reference in any filing
under the Securities Act of 1933, as amended, or the Exchange Act, except as
shall be expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
The following exhibit is being furnished herewith.
Exhibit No.           Description

99.1                    Press release, dated November 5, 2020.

104                   Cover Page Interactive Data File (embedded within the Inline XBRL document)


--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about VYNE THERAPEUTICS INC.
01/22VYNE THERAPEUTICS : Announces Contract Execution for AMZEEQ and ZILXI with Major..
AQ
01/21VYNE THERAPEUTICS : Signs Deal With Pharmacy Benefit Manager for FDA-Approved Sk..
MT
01/21VYNE THERAPEUTICS : Announces Contract Execution for AMZEEQ® (minocycline) and Z..
AQ
01/07VYNE THERAPEUTICS INC. : Regulation FD Disclosure, Financial Statements and Exhi..
AQ
01/05VYNE THERAPEUTICS : to Present at the LifeSci Partners 10th Annual Healthcare Co..
AQ
2020VYNE THERAPEUTICS : Completes End-of-Phase 2 Meeting With FDA for FCD105 to Trea..
MT
2020VYNE Therapeutics Reports Successful End-of-Phase 2 Meeting with the FDA for ..
GL
2020VYNE THERAPEUTICS : to Join Nasdaq Biotechnology Index
MT
2020VYNE THERAPEUTICS : Added to Nasdaq Biotechnology Index
AQ
2020VYNE THERAPEUTICS : Wins US Patent for Acne Treatment Amzeeq
MT
More news